Leishmaniases as Re-emerging Diseases / / edited by Farhat Afrin and Hassan Hemeg.

Leishmania parasites plague the mammalian host causing high morbidity and mortality. The parasites persist in the hostile milieu, crippling its defensive arsenal. In the face of mounting resistance to an antiquated drug arsenal, new approaches are urgently desired to keep the infection at bay. Furth...

Full description

Saved in:
Bibliographic Details
:
TeilnehmendeR:
Place / Publishing House:London, United Kingdom : : IntechOpen,, 2018.
Year of Publication:2018
Language:English
Physical Description:1 online resource (viii, 222) :; illlustrations
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993545327804498
ctrlnum (CKB)4970000000100252
(NjHacI)994970000000100252
(oapen)https://directory.doabooks.org/handle/20.500.12854/51562
(EXLCZ)994970000000100252
collection bib_alma
record_format marc
spelling Hassan Hemeg auth
Leishmaniases as Re-emerging Diseases / edited by Farhat Afrin and Hassan Hemeg.
IntechOpen 2018
London, United Kingdom : IntechOpen, 2018.
1 online resource (viii, 222) : illlustrations
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on: online resource; title from PDF information screen (Intech, viewed October 13, 2022).
Includes bibliographical references.
Leishmania parasites plague the mammalian host causing high morbidity and mortality. The parasites persist in the hostile milieu, crippling its defensive arsenal. In the face of mounting resistance to an antiquated drug arsenal, new approaches are urgently desired to keep the infection at bay. Furthermore, to strengthen the leishmaniasis elimination drive, particular emphasis has to be laid on identification of new targets and vaccination strategies. This book gives a brief glimpse of the epidemiology of leishmaniasis, immune evasion, vaccination, and therapeutic modalities that may work by untangling the immunological cross-wires of pathogenic cross-talk. The Conventional treatment and its drawbacks, the prospects of phytotherapy and nanomedicines, are also discussed. The identification of drug targets with the aim of designing inhibitors is also exemplified.
English
Leishmaniasis Epidemiology.
Leishmaniasis.
Medicine
Internal Medicine
Infectious Diseases
Health Sciences
1-78984-101-1
Hemeg, Hassan, editor.
Afrin, Farhat, editor.
language English
format eBook
author Hassan Hemeg
spellingShingle Hassan Hemeg
Leishmaniases as Re-emerging Diseases /
author_facet Hassan Hemeg
Hemeg, Hassan,
Afrin, Farhat,
author_variant h h hh
author2 Hemeg, Hassan,
Afrin, Farhat,
author2_variant h h hh
f a fa
author2_role TeilnehmendeR
TeilnehmendeR
author_sort Hassan Hemeg
title Leishmaniases as Re-emerging Diseases /
title_full Leishmaniases as Re-emerging Diseases / edited by Farhat Afrin and Hassan Hemeg.
title_fullStr Leishmaniases as Re-emerging Diseases / edited by Farhat Afrin and Hassan Hemeg.
title_full_unstemmed Leishmaniases as Re-emerging Diseases / edited by Farhat Afrin and Hassan Hemeg.
title_auth Leishmaniases as Re-emerging Diseases /
title_new Leishmaniases as Re-emerging Diseases /
title_sort leishmaniases as re-emerging diseases /
publisher IntechOpen
IntechOpen,
publishDate 2018
physical 1 online resource (viii, 222) : illlustrations
isbn 1-83881-521-X
1-78984-102-X
1-78984-101-1
callnumber-first R - Medicine
callnumber-subject RC - Internal Medicine
callnumber-label RC153
callnumber-sort RC 3153 L457 42018
illustrated Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.9364
dewey-sort 3616.9364
dewey-raw 616.9364
dewey-search 616.9364
work_keys_str_mv AT hassanhemeg leishmaniasesasreemergingdiseases
AT hemeghassan leishmaniasesasreemergingdiseases
AT afrinfarhat leishmaniasesasreemergingdiseases
status_str n
ids_txt_mv (CKB)4970000000100252
(NjHacI)994970000000100252
(oapen)https://directory.doabooks.org/handle/20.500.12854/51562
(EXLCZ)994970000000100252
carrierType_str_mv cr
is_hierarchy_title Leishmaniases as Re-emerging Diseases /
author2_original_writing_str_mv noLinkedField
noLinkedField
_version_ 1796649061619597312
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01128nam a2200325 i 4500</leader><controlfield tag="001">993545327804498</controlfield><controlfield tag="005">20221013103448.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">221013s2018 enka ob 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1-83881-521-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1-78984-102-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4970000000100252</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994970000000100252</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/51562</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994970000000100252</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC153</subfield><subfield code="b">.L457 2018</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.9364</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hassan Hemeg</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Leishmaniases as Re-emerging Diseases /</subfield><subfield code="c">edited by Farhat Afrin and Hassan Hemeg.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">IntechOpen</subfield><subfield code="c">2018</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London, United Kingdom :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2018.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (viii, 222) :</subfield><subfield code="b">illlustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from PDF information screen (Intech, viewed October 13, 2022).</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Leishmania parasites plague the mammalian host causing high morbidity and mortality. The parasites persist in the hostile milieu, crippling its defensive arsenal. In the face of mounting resistance to an antiquated drug arsenal, new approaches are urgently desired to keep the infection at bay. Furthermore, to strengthen the leishmaniasis elimination drive, particular emphasis has to be laid on identification of new targets and vaccination strategies. This book gives a brief glimpse of the epidemiology of leishmaniasis, immune evasion, vaccination, and therapeutic modalities that may work by untangling the immunological cross-wires of pathogenic cross-talk. The Conventional treatment and its drawbacks, the prospects of phytotherapy and nanomedicines, are also discussed. The identification of drug targets with the aim of designing inhibitors is also exemplified.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Leishmaniasis</subfield><subfield code="x">Epidemiology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Leishmaniasis.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Internal Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Infectious Diseases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Health Sciences</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-78984-101-1</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hemeg, Hassan,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Afrin, Farhat,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-02-22 20:02:10 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-04-13 22:04:18 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5351645710004498&amp;Force_direct=true</subfield><subfield code="Z">5351645710004498</subfield><subfield code="b">Available</subfield><subfield code="8">5351645710004498</subfield></datafield></record></collection>